A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy

References

• Andeep SC, Madgulkar AR, Kshirsagar SJ, et al. (2012). Amorphous nanoparticles for solubility enhancement. J Adv Pharm Sci 2:167–78
   Google Scholar
• Dong H, Bai LP, Wong KW, et al. (2011). The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives. Molecules 16:10619–30
   PubMed Web of Science ®Google Scholar
• Du D, Liu S, Chen J, et al. (2005). Colloidal gold nanoparticle modified carbon paste interface for studies of tumor cell adhesion and viability. Biomaterials 26:6487–95
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. (2012). Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157:168–82
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang D, Chen MH, et al. (2008). Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res 10:845–62
   Web of Science ®Google Scholar
• Grama CN, Ankola DD, Ravi Kumar MNV. (2011). Poly (lactide-co-glycolide) nano-particles for peroral delivery of bioactives. Curr Opin Colloid Interface Sci 16:238–45
   Web of Science ®Google Scholar
• Han MH, Chen J, Chen SL, et al. (2010). Development of a UPLC-ESI-MS/MS assay for 20(S)-protopanaxadiol and pharmacokinetic application of its two formulations in rats. Anal Sci 26: 749–53
   PubMed Web of Science ®Google Scholar
• Han MH, Chen J, Wang YQ, et al. (2013). Determination of 20(S)-protopanaxadiol in rat plasma by LC-MS/MS method and its application to the pharmacokinetic study: a comparative study of its solution and two oral formulations. J Anal Chem 68:1–6
   Web of Science ®Google Scholar
• Hasegawa H, Lee KS, Nagaoka T, et al. (2000). Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatly acid esters. Biol Pharm Bull 23:298–304
   PubMed Web of Science ®Google Scholar
• Hintz RJ, Johnson KC. (1989). The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm 51:9–17
   Web of Science ®Google Scholar
• Iishi H, Tatsuta M, Baba M, et al. (1997). Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 15:603–11
   PubMed Web of Science ®Google Scholar
• Jacobs C, Kayser O, Muller RH. (2000). Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm 196:161–4
   PubMed Web of Science ®Google Scholar
• Jia L, Wong HC, Cerna S, et al. (2002). Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharm Res 19:1091–6
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang ZH, Li SL, et al. (2013a). A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption. Fitoterapia 84:64–71
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang ZH, Sun E, et al. (2013b). Study on pharmacokinetics of 20 (S)-protopanaxadiol lipid cubic nanoparticles. Zhongguo Zhong Yao Za Zhi 38:263–8
   PubMedGoogle Scholar
• Jin X, Zhang ZH, Sun E, et al. (2013c). Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies. Int J Nanomed 8:641–52
   PubMed Web of Science ®Google Scholar
• Keck CM, Müller RH. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur Pharm Biopharm 62:3–16
   PubMed Web of Science ®Google Scholar
• Lamprecht A. (2010). IBD: selective nanoparticle adhesion can enhance colitis therapy. Nat Rev Gastroenterol Hepatol 7:311–12
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Koening P, Ubrich N, et al. (2006). Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells. Nanotechnology 17:3673–80
   Web of Science ®Google Scholar
• Lee SJ, Ko WG, Kim JH, et al. (2000). Introduction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem Pharmacol 60:677–85
   PubMed Web of Science ®Google Scholar
• Li G, Wang Z, Sun Y, et al. (2006). Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells. Basic Clin Pharmacol Toxicol 98:588–92
   PubMed Web of Science ®Google Scholar
• Li L, Chen X, Li D, et al. (2011). Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes. Drug Metab Dispos 39:472–83
   PubMed Web of Science ®Google Scholar
• Li W, Liu Y, Zhang JW, et al. (2009). Anti-androgen-independent prostate cancer effects of ginsenoside metabolites in vitro: mechanism and possible structure–activity relationship investigation. Arch Pharm Res 32:49–57
   PubMed Web of Science ®Google Scholar
• Li XM, Gu L, Xu YL, et al. (2009). Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev Ind Pharm 35:827–33
   PubMed Web of Science ®Google Scholar
• Liu GY, Bu X, Yan H, et al. (2007). 20(S)-protopanaxadiol-induced programmed cell death in glioma cells through caspase-dependent and -independent pathways. J Nat Prod 70:259–64
   PubMed Web of Science ®Google Scholar
• Lou HY, Gao L, Wei XB, et al. (2011). Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids Surf B: Biointerfaces 87:319–25
   PubMed Web of Science ®Google Scholar
• Morita T, Horikiri Y, Suzuki T, et al. (2001). Preparation of gelatin microparticles by co-lyophilization with poly (ethylene glycol): characterization and application to entrapment into biodegradable microspheres. Int J Pharm 219:127–37
   PubMed Web of Science ®Google Scholar
• Ota T, Maeda AM, Odashima S. (1991). Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. J Pharm Sci 80:1141–6
   PubMed Web of Science ®Google Scholar
• Popovich DG, Kitts DD. (2002). Structure–function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 406:1–8
   PubMed Web of Science ®Google Scholar
• Popovich DG, Kitts DD. (2004). Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2. Can J Physiol Pharmacol 82:183–90
   PubMed Web of Science ®Google Scholar
• Usami Y, Liu YN, Lin AS, et al. (2008). Antitumor agents. 20(S)-protopanaxadiol and 20(S)-protopanaxatriol as antiangiogenic agents and total assignment of 1H NMR spectra. J Nat Prod 71:478–81
   PubMed Web of Science ®Google Scholar
• Wang W, Zhao YQ, Rayburn ER, et al. (2007). In vitro anti-cancer activity and structure–activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59:589–601
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang J, Xu T. (2007). Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo. Toxicol Appl Pharmacol 218:88–95
   PubMed Web of Science ®Google Scholar
• Xia HJ, Zhang ZH, Jin X, et al. (2013). A novel drug–phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo. Int J Nanomed 8:545–54
   PubMed Web of Science ®Google Scholar
• Yardley DA. (2013). nab-Paclitaxel mechanisms of action and delivery. J Control Release 170:365–72
   PubMed Web of Science ®Google Scholar
• Ye Q, Zhang ZC, Jia HT, et al. (2002). Formation of monodisperse polyacrylamide particles by radiation-induced dispersion polymerization: particle size and size distribution. J Colloid Interface Sci 253:279–84
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhou O, Hang Y, et al. (2007). Antiestrogenic effect of 20(S)-protopanaxadiol and its synergy with tamoxifen on breast cancer cells. Cancer 109:2374–82
   PubMed Web of Science ®Google Scholar
• Zhang LY, Yang M, Wang Q, et al. (2007). 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J Contorl Release 119:153–62
   PubMed Web of Science ®Google Scholar
• Zhu GY, Li YW, Tse AKW, et al. (2011). 20(S)-protopanaxadiol, a metabolite of ginsenosides, induced cell apoptosis through endoplasmic reticulum stress in human hepatocarcinoma HepG2 cells. Eur J Pharmacol 668:88–98
   PubMed Web of Science ®Google Scholar